Semaglutide Titration (Standard Research Protocol)
Safety Advisory
Gastrointestinal distress is the primary limiting factor. Do not skip titration steps.
Protocol Description
The STEP trial schedule. Month 1: 0.25mg weekly. Month 2: 0.5mg weekly. Month 3: 1.0mg weekly. Month 4: 1.7mg weekly. Month 5+: 2.4mg weekly (Max).
Community Logs
0 VERIFIED ENTRIESNo logs recorded for this protocol yet.
Be the first to contribute data.